A major breakthrough in cancer research is arising with the use of mini-antibodies to restore dysfunctional p53. This vital malignant inhibitor protein is frequently inactivated in many kinds of malignancies, resulting https://dailybookmarkhit.com/story22046853/mini-antibodies-reactivate-tumor-suppressor-p53-new-promising-approach-for-malignant-treatment